SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anheuser-Busch InBev S.A. – ‘6-K’ for 10/31/14 – ‘EX-99.1’

On:  Friday, 10/31/14, at 5:16pm ET   ·   For:  10/31/14   ·   Accession #:  1193125-14-392221   ·   File #:  1-34455

Previous ‘6-K’:  ‘6-K’ on / for 10/31/14   ·   Next:  ‘6-K’ on / for 2/27/15   ·   Latest:  ‘6-K’ on / for 10/4/16

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/31/14  Anheuser-Busch InBev S.A.         6-K        10/31/14    2:529K                                   Donnelley … Solutions/FA

Current Report by a Foreign Private Issuer   —   Form 6-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current Report by a Foreign Private Issuer          HTML     11K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    371K 


EX-99.1   —   Miscellaneous Exhibit


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-99.1  

Exhibit 99.1

 

PRESS RELEASE

 

Brussels, 31 October 2014 – 1 / 18

   LOGO

The enclosed information constitutes regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market.

Anheuser-Busch InBev reports Third Quarter and Nine Months 2014 Results

Highlights

Except where otherwise stated, the comments below are based on organic figures and refer to 3Q14 and 9M14 versus the same period of last year. For important notes and disclaimers please refer to page 13

 

  Revenue growth: Revenue grew by 2.3% in 3Q14 and by 5.3% in 9M14, with revenue per hl growth of 5.0% in 3Q14 and 4.5% in 9M14. On a constant geographic basis, revenue per hl grew by 4.9% in 3Q14 and by 5.2% in 9M14

 

  Volume performance: Total volumes in 3Q14 declined by 2.6%, with own beer volumes decreasing by 2.7%, while non-beer volumes declined by 0.9%.

 

    US beer sales-to-wholesalers (STWs) declined by 3.7%, with selling-day adjusted sales-to-retailers (STRs) declining by 1.9%

 

    Volumes in Mexico grew by 2.9%, with strong performances by Corona, Bud Light and Victoria

 

    Beer volumes in Brazil grew by 0.2%, being impacted by a soft consumer environment

 

    Volumes in China declined by 4.9%, mainly due to cold temperatures in August and September.

In 9M14, total volumes grew by 0.8%, with own beer volumes up 0.6% and non-beer volumes up 2.6%

 

  Focus Brands: Volumes of our global brands grew by 3.1% in 3Q14, led by global Corona which grew by 6.7%, and global Budweiser which grew by 2.8%. Our total Focus Brands volumes declined by 1.0% in the quarter

 

  Cost of Sales: Cost of Sales (CoS) increased by 2.9% in 3Q14, and by 5.6% on a per hl basis, driven by higher depreciation charges related to recent investments in Brazil, and additional packaging costs in Mexico related to higher than expected demand for Corona. In 9M14, CoS grew by 1.8%, and by 1.0% on a per hl basis. On a constant geographic basis, CoS per hl increased by 6.7% in 3Q14 and by 2.6% in 9M14

 

  EBITDA: EBITDA grew by 1.3% in 3Q14 to 4 745 million USD, with a margin contraction of 37 bps to 38.8%. A strong revenue per hl performance in the quarter was partly offset by the difference between STWs and STRs in the US, the phasing of our revenue management initiatives in Brazil, and a very tough comparable in Mexico cost synergies. In 9M14, EBITDA grew by 6.9% to 13 476 million USD with a margin of 38.5%, an improvement of 59 bps

 

  Net finance costs: Net finance costs (excl. non-recurring net finance costs) were 366 million USD in the quarter, compared to 562 million USD in 3Q13, driven by lower interest expense and currency gains, while 3Q13 net finance costs included negative currency results

 

  Income taxes: Income tax expense in 3Q14 was 684 million USD, with a normalized effective tax rate (ETR) of 19.7%, compared to an income tax expense of 699 million USD in 3Q13 and a normalized ETR of 21.3%. The normalized ETR in 9M14 was 18.9% compared to 18.1% in 9M13

 

  Profit: Normalized profit attributable to equity holders of AB InBev increased in nominal terms to 2 315 million USD in 3Q14 from 2 205 million USD in 3Q13. Normalized profit attributable to equity holders of AB InBev increased in nominal terms to 6 345 million USD in 9M14 from 5 562 million USD in 9M13

 

  Earnings per share (EPS): Normalized EPS increased to 1.42 USD in 3Q14 from 1.36 USD in 3Q13. Normalized EPS increased to 3.89 USD in 9M14 compared with 3.45 USD in 9M13

 

  Interim Dividend: The AB InBev Board has approved an interim dividend of 1.00 EUR per share for the fiscal year 2014. The shares will trade ex-coupon as of 12 November 2014, and dividends will be payable as from 14 November 2014. The record date will be 13 November 2014


PRESS RELEASE

 

Brussels, 31 October 2014 – 2 / 18

   LOGO

 

Figure 1. Consolidated performance (million USD)                         
     3Q13
Reported
    3Q13
Reference Base
    3Q14     Organic
growth
 

Total Volumes (thousand hls)

     119 664        119 664        120 651        -2.6

AB InBev own beer

     107 907        107 907        108 527        -2.7

Non-beer volumes

     11 206        11 206        11 105        -0.9

Third party products

     551        551        1 019        -1.0

Revenue

     11 729        11 712        12 239        2.3

Gross profit

     6 972        6 962        7 273        1.9

Gross margin

     59.4     59.4     59.4     -24 bp   

Normalized EBITDA

     4 664        4 659        4 745        1.3

Normalized EBITDA margin

     39.8     39.8     38.8     -37 bp   

Normalized EBIT

     3 908        3 904        3 895        -0.7

Normalized EBIT margin

     33.3     33.3     31.8     -98 bp   

Profit attributable to equity holders of AB InBev

     2 366          2 499     

Normalized profit attributable to equity holders of AB InBev

     2 205          2 315     

Earnings per share (USD)

     1.44          1.53     

Normalized earnings per share (USD)

     1.36          1.42     
     9M13
Reported
    9M13
Reference Base
    9M14     Organic
growth
 

Total Volumes (thousand hls)

     315 497        335 344        345 646        0.8

AB InBev own beer

     281 038        300 884        309 359        0.6

Non-beer volumes

     32 930        32 931        33 774        2.6

Third party products

     1 529        1 529        2 513        1.5

Revenue

     31 484        33 787        35 045        5.3

Gross profit

     18 372        19 707        20 925        7.8

Gross margin

     58.4     58.3     59.7     138 bp   

Normalized EBITDA

     11 989        12 748        13 476        6.9

Normalized EBITDA margin

     38.1     37.7     38.5     59 bp   

Normalized EBIT

     9 838        10 439        11 076        7.0

Normalized EBIT margin

     31.2     30.9     31.6     51 bp   

Profit attributable to equity holders of AB InBev

     11 875          6 689     

Normalized profit attributable to equity holders of AB InBev

     5 562          6 345     

Earnings per share (USD)

     7.36          4.10     

Normalized earnings per share (USD)

     3.45          3.89     

 

Figure 2. Volumes (thousand hls)                                   
                                 Organic growth  
    

3Q13

Reference base

     Scope     

Organic

growth

     3Q14      Total
Volume
    Own beer
volume
 

North America

     33 243         211         -1 171         32 283         -3.5     -3.5

Mexico

     9 311         —           267         9 578         2.9     2.9

Latin America - North

     28 830         11         -33         28 808         -0.1     0.3

Latin America - South

     8 167         —           188         8 355         2.3     3.3

Europe

     13 119         37         -1 243         11 912         -9.5     -9.5

Asia Pacific

     23 022         5 592         -1 087         27 527         -4.7     -4.7

Global Export and Holding Companies

     3 972         -1 849         65         2 187         3.0     3.1

AB InBev Worldwide

     119 664         4 000         -3 013         120 651         -2.6     -2.7
                                 Organic growth  
    

9M13

Reference base

     Scope     

Organic

growth

     9M14      Total
Volume
    Own beer
volume
 

North America

     93 968         496         -1 660         92 805         -1.8     -1.8

Mexico

     28 451         —           503         28 954         1.8     1.8

Latin America - North

     84 654         21         4 498         89 173         5.3     5.9

Latin America - South

     25 540         —           239         25 779         0.9     1.3

Europe

     36 479         41         -2 374         34 146         -6.5     -6.7

Asia Pacific

     54 543         11 526         992         67 062         1.8     1.8

Global Export and Holding Companies

     11 708         -4 321         340         7 726         4.6     4.6

AB InBev Worldwide

     335 344         7 764         2 539         345 646         0.8     0.6


PRESS RELEASE

 

Brussels, 31 October 2014 – 3 / 18

   LOGO

 

MANAGEMENT COMMENTS

This quarter was marked by a solid underlying commercial performance in our top markets, with revenues growing by 2.3%, and revenue per hl growing by 4.9%, on a constant geographic basis. However, EBITDA grew by only 1.3%, as a result primarily of: the difference between STWs (-3.7%) and STRs (-1.9%) in the US; the phasing of our revenue management initiatives in Brazil (beer net revenue per hl growing by only 1.2%); and a very tough comparable in Mexico cost synergies which represents approximately four percentage points of organic EBITDA growth at the consolidated level.

We believe that the third quarter was a one-off in terms of EBITDA performance, and is not reflective of expected future trends for the business. We have a clear strategy built around long term sustainable top-line growth, and are pleased with the direction in which we are heading.

We gained market share at the consolidated level, both in the quarter and in the nine months, with strong performances in Brazil and China, in particular, as well as improved share trends in the US, based on our estimates.

Our own beer volumes declined by 2.7% in the quarter, with Europe accounting for over 40% of this decline driven by Russia and Ukraine. However, we saw good progress in all four of our top markets:

 

    In the US, our market share showed good improvement, declining by 30 bps compared to 65 bps in the second quarter, with good performances from Bud Light, Michelob Ultra, and our high end brands. We are also pleased that our investments in the On-premise are starting to deliver results

 

    Our beer volumes in Mexico grew by 2.9%, the best volume performance since the closing of the combination with Grupo Modelo, with growth being driven by Corona, Bud Light and Victoria

 

    We gained 100 bps of market share in Brazil, reaching 69.0%, with our beer volumes marginally ahead of the same period last year, despite a soft consumer environment. We continue to benefit from the momentum built by our mainstream brands during the FIFA World Cup, as well as strong volume growth from our premium brand portfolio, especially Budweiser

 

    In China, our Focus Brands continue to perform well. Our market share increased organically by 70 bps to 15.7% in the first nine months of the year, and to 16.5% when including our recent acquisitions, based on our estimates. Industry beer volumes in China were impacted significantly by record cold temperatures in August and September, in contrast to record high temperatures last year.

We are continuing to invest behind our brands, with our Global and Focus brands performing ahead of the total portfolio. Volumes of our Global Brands grew by 3.1%, with particularly strong performances from Corona and Budweiser.

OUTLOOK

Our outlook for full year 2014 is as follows:

 

(i) Volumes: We expect an improvement in the trend of US industry volumes compared to 2013, driven by a stronger economy, partly offset by challenging winter weather in 1Q14. We expect the Mexican beer industry to return to growth in FY14, driven by a stronger economy, as well as our own commercial programs. We expect Brazil beer industry volumes to resume growth in FY14, helped by the 2014 FIFA World Cup. We expect a year of solid volume growth in China

 

(ii) Revenue per hl: We expect revenue per hl to grow organically in line with inflation, on a constant geographic basis, as a result of continued improvement in mix and revenue management initiatives

 

(iii) Cost of Sales per hl: We expect CoS per hl to increase organically by low single digits, on a constant geographic basis, driven by mix and unfavorable foreign exchange transactional impact (primarily BRL/USD), partly offset by favorable global commodity prices, procurement savings and efficiency gains

 

(iv) Distribution expenses per hl: We expect distribution expenses per hl to increase organically by mid-single digits, driven by higher distribution expenses in Brazil, the US and Mexico

 

(v) Sales & Marketing investments: We expect a low to mid-teens percentage increase in our sales and marketing investments as we continue to drive top-line performance by supporting our brands. This increase includes investment behind our innovations, the 2014 FIFA World Cup and the scaling up of proven trade marketing programs. We expect the increase in sales and marketing investments to be weighted towards the first half of the year


PRESS RELEASE

 

Brussels, 31 October 2014 – 4 / 18

   LOGO

 

(vi) Net Finance Costs: We are amending our guidance on the average coupon on net debt. We now expect the average coupon on net debt to be at the lower end of our previous guidance of a 4.0% to 4.5% range. Net pension interest expense and accretion expenses are expected to be approximately 35 and 80 million USD per quarter, respectively. Other financial results will continue to be impacted by the potential gains and losses related to the hedging of our share-based payment programs

 

(vii) Effective Tax Rate: We are amending our guidance on the effective tax rate. Our previous guidance was for the normalized ETR in FY14 to be between 21% and 23%. We now expect the result in FY14 to be at the lower end of this range. We expect the normalized ETR to be in the range of 22% to 25% in the period 2015-2017, and in the range of 25% to 27% thereafter

 

(viii) Net Capital Expenditure: Our previous guidance for net capital expenditure in FY14 was approximately 4.0 billion USD. We are amending this guidance to approximately 3.7 billion USD

 

(ix) Debt: Our optimal capital structure remains a net debt to EBITDA ratio of around 2.0x. Approximately one third of AB InBev’s gross debt is denominated in currencies other than the US dollar, principally the Euro.

BUSINESS REVIEW

United States

Key performance indicators

 

Figure 3. United States (million USD)                   
     3Q13
Reference Base
    3Q14     Organic
growth
 

Total volumes (thousand hls)

     30 660        29 566        -3.7

Revenue

     3 794        3 703        -2.6

Normalized EBITDA

     1 602        1 490        -7.1

Normalized EBITDA margin

     42.2     40.2     -197 bp   

 

     9M13
Reference Base
    9M14     Organic
growth
 

Total volumes (thousand hls)

     87 067        85 613        -1.8

Revenue

     10 804        10 788        -0.3

Normalized EBITDA

     4 544        4 677        -2.1

Normalized EBITDA margin

     42.1     43.4     -74 bp   

In the United States, we estimate industry selling-day-adjusted STRs were down 1.3% in 3Q14, and down 0.8% in 9M14, an improvement over a reported decline of 2.2% in 9M13. Our own selling-day adjusted STRs were down 1.9% in 3Q14, and down 1.8% in 9M14.

Our STWs declined by 3.7% in 3Q14 and by 1.8% in 9M14. We have now completed the planned adjustments to wholesaler inventories, following the closing of labor negotiations at the beginning of 2Q14, and continue to expect STWs and STRs to converge, in absolute terms, on a full year basis.

Our market share performance in 3Q14 improved compared to the first half, based on our estimates. We estimate market share was down approximately 30 bps in the quarter, compared to a decline of 65 bps in 2Q14, and a decline of 55 bps in HY14. We are particularly pleased with our progress in the On-premise, which has been driven by the performance of Bud Light and our high end brands.

The Bud Light brand continues to make good progress. Bud Light STRs were down approximately 2% in 3Q14, leading to a loss in total market share of 20 bps, while gaining share of premium light, according to our estimates. This performance was driven by the new “Up For Whatever” campaign which was launched at the start of the year and which continued throughout the summer, as well as our new 25oz can and 16oz aluminum bottle packages. The Ritas family also performed well, delivering a market share gain of 10 bps, based on our estimates. We estimate that market share for the Bud Light family was down 20 bps in both 3Q14 and 9M14.


PRESS RELEASE

 

Brussels, 31 October 2014 – 5 / 18

   LOGO

 

The total estimated market share of the Budweiser family was down approximately 40 bps in the quarter, with trends improving in recent weeks. In the coming months we expect the brand to benefit from the new 16oz re-closeable aluminum bottle which was extended to include Budweiser at the start of September.

Michelob Ultra continues to deliver strong share growth, with an estimated gain of 20 bps in the quarter. We estimate our other high end brands also grew share by an estimated 20 bps. Montejo, our authentic Mexican brand, is also off to a good start in the four pilot states of California, Texas, Arizona and New Mexico after the launch at the beginning of September.

Our Value brands had a strong quarter, driven by our 25oz can, gaining share of both the segment and the total market based on our estimates.

US beer only revenue per hl grew by 1.2% in the quarter and by 1.5% in 9M14. As expected, the third quarter result was impacted by a negative package mix from the 25oz can. This new package was launched in 4Q13, and so we anticipate having a more favorable comparable in the fourth quarter.

US EBITDA was down 7.1% in the quarter, with margin contraction of 197 bps. This result was driven by the difference between STWs and STRs, higher distribution expenses due to increased freight rates, and increased investment behind our brands. US EBITDA declined by 2.1% in 9M14, with an EBITDA margin contraction of 74 bps.

Mexico

Key performance indicators

 

Figure 4. Mexico (million USD)                   
     3Q13
Reference Base
    3Q14     Organic
growth
 

Total volumes (thousand hls)

       9 311          9 578        2.9

Revenue

     1 150        1 132        8.2

Normalized EBITDA

     533        568        16.5

Normalized EBITDA margin

     46.3     50.2     357 bp   

 

     9M13
Reference Base
    9M14     Organic
growth
 

Total volumes (thousand hls)

     28 452        28 954        1.8

Revenue

     3 485        3 471        5.0

Normalized EBITDA

     1 369        1 630        25.8

Normalized EBITDA margin

     39.3     47.0     775 bp   

We estimate Mexican beer industry volumes grew by low single digits in 3Q14, driven by a stronger economy and a good performance from our own Focus Brands. Our own volumes grew by 2.9% in the quarter, driven by the industry. The glass shortages, which negatively impacted both sales and cost of sales in the quarter, have improved at this point.

Our Focus Brands grew by mid-single digits in both 3Q14 and 9M14. The Corona brand family continued to perform well, growing by 4.6% in the quarter and by 8.3% in 9M14. We are also very pleased with the performance of Bud Light, with volumes more than doubling compared to 3Q13, and Victoria which responded well to a new campaign launched during the quarter. The renovation of the Modelorama chain is continuing, with the new store image providing improved consumer appeal and visibility for the Corona brand.

Beer revenue per hl grew by 4.4% in 3Q14 reflecting our revenue management initiatives, and brand mix driven by the strong performance of Bud Light.

Cost synergies realized during the third quarter amounted to approximately 10 million USD, against a tough comparable in 3Q13, when we reported cost synergies of over 200 million dollars. The total cost savings to date amount to approximately 725 million USD. We remain committed to delivering 1 billion USD in cost synergies by the end of 2016, with the majority expected to come by the end of 2015.


PRESS RELEASE

 

Brussels, 31 October 2014 – 6 / 18

   LOGO

 

Mexico EBITDA grew by 16.5% to 568 million USD in 3Q14, with an EBITDA margin enhancement of 357 bps to 50.2%, despite a tough cost synergies comparable. The increase in EBITDA was driven by the strong volume and revenue per hl performance, partly offset by additional packaging costs related to higher than expected demand for Corona in Mexico and overseas markets. Mexico EBITDA grew by 25.8% in 9M14, with EBITDA margin increasing to 47.0%.

Brazil

Key performance indicators

 

Figure 5. Brazil (million USD)                   
     3Q13
Reference Base
    3Q14     Organic
growth
 

Total volumes (thousand hls)

     26 908        26 792        -0.4

Beer volumes

     19 635        19 676        0.2

Non-beer volumes

     7 272        7 116        -2.2

Revenue

     2 263        2 382        1.1

Normalized EBITDA

     1 240        1 210        -5.3

Normalized EBITDA margin

     54.8     50.8     -349 bp   

 

     9M13
Reference Base
    9M14     Organic
growth
 

Total volumes (thousand hls)

     79 482        83 636        5.2

Beer volumes

     58 328        61 895        6.1

Non-beer volumes

     21 154        21 741        2.8

Revenue

     7 033        7 209        10.7

Normalized EBITDA

     3 544        3 474        5.9

Normalized EBITDA margin

     50.4     48.2     -219 bp   

Brazil beer industry volumes declined by 1.2% in 3Q14, based on our estimates, due to a soft consumer environment. We estimate that industry volumes grew by 5.9% in 9M14, benefiting from a strong summer and the FIFA World Cup.

Our total volumes declined by 0.4% in the quarter, with our beer volumes up 0.2% and our soft drinks volumes down 2.2%. Our year to date volume performance remains solid, with total volumes up 5.2%, beer volumes up 6.1% and soft drinks volumes up 2.8%.

Our beer market share performance has been strong all year. We estimate that our share in 3Q14 increased to 69.0%, an increase of 60 bps compared to 2Q14, and 100 bps compared to 3Q13. We estimate that our year-over-year market share for 9M14 was up 10 bps to 68.2%. Our premium brands continue to outperform the rest of the portfolio, with a strong performance by Budweiser, which expanded its position as the leading international brand in Brazil, based on our estimates.

Brazil beer revenue per hl increased by only 1.2% in the quarter, due to the phasing of our revenue management initiatives, and by 4.7% in 9M14. On a sequential basis, beer revenue per hl increased by 3.0%, reflecting the end of price promotions put in place during the FIFA World Cup. The consumer environment in Brazil continues to be challenging, and our pack price and returnables strategies, remain major business priorities.

Brazil EBITDA declined by 5.3% in 3Q14 to 1 210 million USD, with a margin decline of 349 bps to 50.8%. This result was due to the combined impact of flat volumes and the low revenue per hl growth. We also faced a difficult comparable in other operating income following the reporting of a gain in 3Q13 related to the favorable outcome of legal proceedings. Brazil EBITDA grew by 5.9% in 9M14, with an EBITDA margin contraction of 219 bps.


PRESS RELEASE

 

Brussels, 31 October 2014 – 7 / 18

   LOGO

 

China

Key performance indicators

 

Figure 6. China (million USD)                   
     3Q13
Reference Base
    3Q14     Organic
growth
 

Total volumes (thousand hls)

     22 962        23 543        -4.9

Revenue

     1 096        1 192        4.6

Normalized EBITDA

     228        271        20.0

Normalized EBITDA margin

     20.8     22.7     305 bp   

 

     9M13
Reference Base
    9M14     Organic
growth
 

Total volumes (thousand hls)

     54 337        59 102        1.7

Revenue

     2 703        3 127        11.1

Normalized EBITDA

     500        714        40.7

Normalized EBITDA margin

     18.5     22.8     493 bp   

The beer industry in China was impacted significantly by cold weather in 3Q14, especially in the southeastern and central regions. This unfavorable weather contrasts with a long, hot summer last year, when our volumes grew by over 8% in 3Q13.

Our own volumes in China declined by 4.9% in 3Q14, and increased by 1.7% in 9M14 due to a strong first half growth of 6.5%. Our Focus Brands of Budweiser, Harbin and Sedrin, which represent nearly 75% of our portfolio, grew by 3.7% in the quarter, and by more than 8% in 9M14, with Budweiser continuing to perform very well, growing by double digits in both the quarter and nine months. We estimate that on an organic basis, we gained approximately 70 bps of market share in 9M14, reaching 15.7%. We estimate market share reached 16.5% in 9M14 when including our recent acquisitions.

We added Corona to our premium brand portfolio in China at the beginning of August. Brand volumes are very small today, but we expect significant growth in the medium to long term.

Revenue per hl grew by 8.3% in 3Q14 and by 8.5% in 9M14. This result was driven mainly by improved brand mix, with consumers trading up to our more premium priced brands, specifically Budweiser and Harbin Ice.

China EBITDA grew by 20.0% in 3Q14 driven by top-line growth and good cost management, partly offset by higher cost of sales and distribution expenses related to brand mix. EBITDA margin in 3Q14 increased by 305 bps to 22.7%. EBITDA grew by 40.7% in 9M14 with a margin improvement of 493 bps to 22.8%.

Highlights from our other top markets

Although the economy remains challenging, the trend of beer industry volumes in Argentina improved in 3Q14, in comparison to 2Q14, driven by warmer weather. Our own beer volumes grew by 2.9% in the quarter, driven mainly by industry performance, and were marginally ahead in 9M14.

Own beer volumes in Belgium declined by 7.2% in 3Q14, and were marginally down in 9M14. The result for the quarter was driven by very poor weather in July and August, against a difficult weather comparable, as well as inventory adjustments following the FIFA World Cup. We estimate that we gained market share in 9M14 with a strong performance in the On-premise channel.

In Canada, our beer volumes declined by 1.0% in both 3Q14 and 9M14, due to industry softness. We estimate that market share was flat in the quarter, with good performances by Bud Light and Stella Artois.

In Germany, own beer volumes declined by 7.4% in 3Q14 and by 3.3% in 9M14, driven by a weak industry and some share loss in the first eight months of the year for which data is available. Our volume performance continued to be impacted by promotional pressure, although we estimate that the market share of Beck’s and Franziskaner remained stable.


PRESS RELEASE

 

Brussels, 31 October 2014 – 8 / 18

   LOGO

 

Our Russia beer volumes remain under pressure, declining by approximately 20% in 3Q14 and 14% in 9M14, due mainly to a weak industry and some estimated market share loss. Our focus continues to be the premiumization of our portfolio and striking the optimal balance between volume, revenue and profitability.

In South Korea, beer volumes were down 3.4% in 3Q14, mainly due to a weak industry, with flat share year over year.

In the United Kingdom, own products were down 9.8% in the quarter as a result of very favorable weather in 3Q13. Volumes were up 1.3% in 9M14. We estimate that we gained market share in 9M14 with a strong performance of our focus brands in the Off-premise.

CONSOLIDATED INCOME STATEMENT

 

Figure 7. Consolidated income statement (million USD)                            
     3Q13
Reported
     3Q13
Reference Base
     3Q14      Organic
growth
 

Revenue

     11 729         11 712         12 239         2.3

Cost of sales

     -4 757         -4 750         -4 966         -2.9

Gross profit

     6 972         6 962         7 273         1.9

Distribution expenses

     -1 078         -1 076         -1 199         -9.0

Sales and marketing expenses

     -1 613         -1 610         -1 809         -7.2

Administrative expenses

     -663         -662         -651         3.5

Other operating income/(expenses)

     290         289         281         11.8

Normalized profit from operations (normalized EBIT)

     3 908         3 904         3 895         -0.7

Non-recurring items above EBIT

     -26            66      

Net finance income/(cost)

     -562            -366      

Non-recurring net finance income/(cost)

     170            103      

Share of results of associates

     5            2      

Income tax expense

     -699            -684      

Profit

     2 796            3 016      

Profit attributable to non-controlling interest

     430            517      

Profit attributable to equity holders of AB InBev

     2 366            2 499      

Normalized EBITDA

     4 664         4 659         4 745         1.3

Normalized profit attributable to equity holders of AB InBev

     2 205            2 315      
     9M13
Reported
     9M13
Reference Base
     9M14      Organic
growth
 

Revenue

     31 484         33 787         35 045         5.3

Cost of sales

     -13 112         -14 080         -14 120         -1.8

Gross profit

     18 372         19 707         20 925         7.8

Distribution expenses

     -3 014         -3 241         -3 424         -7.9

Sales and marketing expenses

     -4 481         -4 862         -5 415         -11.1

Administrative expenses

     -1 737         -1 965         -2 010         -2.7

Other operating income/(expenses)

     698         800         1 000         6.5

Normalized profit from operations (normalized EBIT)

     9 838         10 439         11 076         7.0

Non-recurring items above EBIT

     6 253            -40      

Net finance income/(cost)

     -1 817            -1 614      

Non-recurring net finance income/(cost)

     151            341      

Share of results of associates

     288            13      

Income tax expense

     -1 548            -1 750      

Profit

     13 165            8 026      

Profit attributable to non-controlling interest

     1 290            1 337      

Profit attributable to equity holders of AB InBev

     11 875            6 689      

Normalized EBITDA

     11 989         12 748         13 476         6.9

Normalized profit attributable to equity holders of AB InBev

     5 562            6 345      


PRESS RELEASE

 

Brussels, 31 October 2014 – 9 / 18

   LOGO

 

Revenue

Revenue grew by 2.3% in 3Q14, with revenue per hl growth of 5.0%, driven by revenue management initiatives and brand mix improvements from our premiumization strategies. On a constant geographic basis, revenue per hl grew by 4.9%. In 9M14, revenue grew by 5.3% with revenue per hl growth of 4.5%, or 5.2% on a constant geographic basis.

Cost of Sales (CoS)

Total CoS increased by 2.9% in 3Q14, and by 5.6% on a per hl basis. This performance was due to higher depreciation charges related to recent investments in Brazil, and additional packaging costs in Mexico related to higher than expected demand for Corona in both Mexico and overseas markets, partly mitigated by procurement savings and efficiency gains. On a constant geographic basis, CoS per hl increased by 6.7%. In 9M14, CoS increased by 1.8%, with a CoS per hl increase of 1.0%, or 2.6% on a constant geographic basis.

Distribution expenses

Distribution expenses grew by 9.0% in 3Q14 and by 11.9% on a per hl basis, mainly driven by increases in freight rates in the US, increased own distribution in Brazil, and increased expenses in Mexico. In Latin America South, distribution expenses increased by 27.1% per hectoliter due to higher fuel costs and wage increases for unionized workers. Distribution expenses increased by 7.9% in 9M14 and by 7.1% on a per hl basis.

Sales and marketing investments

Sales and marketing investments increased by 7.2% in 3Q14, with increased support for our brands, innovations and sales activations in most Zones. The increased investments include our FIFA World Cup activations at the start of the quarter, particularly in Latin America North and South, Mexico and Europe, as well as investments behind proven trade marketing programs, and the new Bud Light summer campaign in the United States. Sales and Marketing investments increased by 11.1% in 9M14.

Administrative expenses

Administrative expenses decreased by 3.5% in 3Q14, mainly due to the timing of accruals for variable compensation and other overhead expenses. In 9M14, administrative expenses increased by 2.7%.

Other operating income

Other operating income increased by 11.8% in 3Q14, and by 6.5% in 9M14.

Non-recurring items above EBIT

 

Figure 8. Non-recurring items above EBIT (million USD)                            
     3Q13      3Q14      9M13      9M14  

Restructuring (including impairment losses)

     -56         -29         -118         -80   

Fair value adjustments

     -5         —           6 410         —     

Acquisition costs related to business combinations

     -4         -3         -78         -71   

Business and asset disposal (including impairment losses)

     39         98         39         111   
  

 

 

    

 

 

    

 

 

    

 

 

 

Impact on profit from operations

     -26         66         6 253         -40   

Normalized profit from operations excludes a non-recurring net gain of 66 million USD in 3Q14, primarily due to incremental proceeds from disposals in previous years. Non-recurring items in 9M14 were -40 million USD.

Net finance income/(cost)

 

Figure 9. Net finance income/(cost) (million USD)                            
     3Q13      3Q14      9M13      9M14  

Net interest expense

     -430         -377         -1 330         -1 260   

Net interest on net defined benefit liabilities

     -40         -37         -116         -95   

Accretion expenses

     -83         -79         -236         -237   

Other financial results

     -9         127         -135         -22   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net finance income/(cost)

     -562         -366         -1 817         -1 614   


PRESS RELEASE

 

Brussels, 31 October 2014 – 10 / 18

   LOGO

 

Net finance cost (excluding non-recurring net finance cost) was 366 million USD in 3Q14 compared to 562 million USD in 3Q13. This decrease was driven by lower interest expenses and currency gains reported in other financial results, while 3Q13 included a negative currency result. Other financial results also includes a mark to market gain of 144 million USD linked to the hedging of our share-based payment programs. This compares to a gain of 192 million USD in 3Q13. The number of shares covered by the hedging of our share-based payment programs and the share prices at the beginning and end of the third quarter, are shown in figure 10 below. Net finance costs in 9M14 were 1 614 million USD, compared to 1 817 million USD in 9M13.

 

Figure 10. Share-based payment hedge                            
     3Q13      3Q14      9M13      9M14  

Share price at the start of the period (Euro)

     68.39         83.90         65.74         77.26   

Share price at the end of the period (Euro)

     73.58         88.12         73.58         88.12   

Number of equity instruments (millions)

     28.3         28.7         28.3         28.7   

Non-recurring net finance income/(cost)

 

Figure 11. Non-recurring net finance income/(cost) (million USD)                            
     3Q13      3Q14      9M13      9M14  

Mark-to-market adjustment

     170         103         251         341   

Other

     —           —           -100         —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-recurring net finance income/(cost)

     170         103         151         341   

Non-recurring net finance results were 103 million USD in 3Q14 resulting from the mark-to-market impact of derivative instruments entered into to hedge the deferred share instrument issued in a transaction related to the combination with Grupo Modelo. This compares to a reported gain of 170 million USD in 3Q13. The deferred share instrument was hedged at an average price of approximately 68 EUR per share. The number of shares covered by the hedging of the deferred share instrument, and the opening and closing share prices, are shown in figure 12.

 

Figure 12. Deferred share instrument hedge                            
     3Q13      3Q14      9M13      9M14  

Share price at the start of the period (Euro)

     68.39         83.90         65.74         77.26   

Share price of additional hedges acquired during the period (Euro)

     71.98         —           69.47         —     

Share price at the end of the period (Euro)

     73.58         88.12         73.58         88.12   

Number of deferred share instruments at the start of the period (millions)

     21.5         23.1         9.5         23.1   

Number of deferred share instruments at the end of the period (millions)

     23.0         23.1         23.0         23.1   

Income tax expense

 

Figure 13. Income tax expense (million USD)                         
     3Q13     3Q14     9M13     9M14  

Tax expense

     699        684        1 548        1 750   

Effective tax rate

     20.0     18.5     10.7     17.9

Normalized effective tax rate

     21.3     19.7     18.1     18.9

Income tax in 3Q14 was 684 million USD with a normalized effective tax rate (ETR) of 19.7%, compared to an income tax expense of 699 million USD in 3Q13 and a normalized ETR of 21.3%.

Share of results of associates

3Q14 included a share of results of associates of 1 million USD compared to 5 million USD in 3Q13, and 9M14 included a share of results of associates of 12 million USD compared to 288 million USD in 9M13.

In the first five months of 2013, the share of results of associates reflected AB InBev’s equity investment in Grupo Modelo. Since the combination between Grupo Modelo and AB InBev at the start of June 2013, the results of Grupo Modelo are being fully consolidated.


PRESS RELEASE

 

Brussels, 31 October 2014 – 11 / 18

   LOGO

 

Profit attributable to non-controlling interest

Profit attributable to non-controlling interest increased from 430 million USD in 3Q13 to 517 million USD in 3Q14, due to underlying profit growth. Profit attributable to non-controlling interest increased from 1 290 million USD in 9M13 to 1 337 million USD in 9M14.

Normalized Profit and Profit

 

Figure 14. Normalized Profit attribution to equity holders of AB InBev (million USD)                            
     3Q13      3Q14      9M13      9M14  

Profit attributable to equity holders of AB InBev

     2 366         2 499         11 875         6 689   

Non-recurring items, after taxes, attributable to equity holders of AB InBev

     9         -81         -6 162         -3   

Non-recurring finance (income)/cost, after taxes, attributable to equity holders of AB InBev

     -170         -103         -151         -341   
  

 

 

    

 

 

    

 

 

    

 

 

 

Normalized profit attributable to equity holders of AB InBev

     2 205         2 315         5 562         6 345   

Normalized profit attributable to equity holders of AB InBev was 2 315 million USD in 3Q14 compared to 2 205 million USD in 3Q13, mainly driven by lower net finance costs. In 9M14, normalized profit attributable to equity holders of AB InBev increased to 6 345 million USD from 5 562 million USD in 9M13.

Profit attributable to equity holders of AB InBev was 2 499 million USD in 3Q14, compared to 2 366 million USD in 3Q13, reflecting a non-recurring gain of 81 million USD primarily due to incremental proceeds from disposals in previous years. In 9M14, profit attributable to equity holders of AB InBev decreased to 6 689 million USD from 11 875 million USD in 9M13 reflecting the non-recurring fair value adjustment on the initial investment held in Grupo Modelo, reported in 9M13.

Normalized EPS

 

Figure 15. Earnings per share (USD)                            
     3Q13      3Q14      9M13      9M14  

Basic earnings per share

     1.44         1.53         7.36         4.10   

Non-recurring items, after taxes, attributable to equity holder of AB InBev, per share

     0.02         -0.05         -3.82         —     

Non-recurring finance (income)/cost, after taxes, attributable to equity holders of AB InBev, per share

     -0.10         -0.06         -0.09         -0.21   
  

 

 

    

 

 

    

 

 

    

 

 

 

Normalized earnings per share

     1.36         1.42         3.45         3.89   

Normalized earnings per share (EPS) increased to 1.42 USD in 3Q14 from 1.36 USD in 3Q13 and to 3.89 USD in 9M14 from 3.45 USD in 9M13.


PRESS RELEASE

 

Brussels, 31 October 2014 – 12 / 18

   LOGO

 

Reconciliation between profit attributable to equity holders and normalized EBITDA

 

Figure 16. Reconciliation of normalized EBITDA to profit attributable to equity holders of AB InBev (million USD)  
     3Q13             9M13         
     Reported      3Q14      Reported      9M14  

Profit attributable to equity holders of AB InBev

     2 366         2 499         11 875         6 689   

Non-controlling interests

     430         517         1 290         1 337   

Profit

     2 796         3 016         13 165         8 026   

Income tax expense

     699         684         1 548         1 750   

Share of result of associates

     -5         -2         -288         -13   

Net finance (income)/cost

     562         366         1 817         1 614   

Non-recurring net finance (income)/cost

     -170         -103         -151         -341   

Non-recurring items above EBIT (incl. non-recurring impairment)

     26         -66         -6 253         40   

Normalized EBIT

     3 908         3 895         9 838         11 076   

Depreciation, amortization and impairment

     756         850         2 151         2 400   

Normalized EBITDA

     4 664         4 745         11 989         13 476   

Normalized EBITDA and normalized EBIT are measures utilized by AB InBev to demonstrate the company’s underlying performance. Normalized EBITDA is calculated excluding the following effects from profit attributable to equity holders of AB InBev: (i) non-controlling interest; (ii) income tax expense; (iii) share of results of associates; (iv) net finance cost; (v) non-recurring net finance cost; (vi) non-recurring items above EBIT (including non-recurring impairment); and (vii) depreciation, amortization and impairment.

Normalized EBITDA and normalized EBIT are not accounting measures under IFRS accounting and should not be considered as an alternative to profit attributable to equity holders as a measure of operational performance, or an alternative to cash flow as a measure of liquidity. Normalized EBITDA and normalized EBIT do not have a standard calculation method and AB InBev’s definition of normalized EBITDA and normalized EBIT may not be comparable to that of other companies.


PRESS RELEASE

 

Brussels, 31 October 2014 – 13 / 18

   LOGO

 

NOTES

AB InBev’s 3Q14 and 3Q13 and 9M14 and 9M13 reported numbers are based on condensed unaudited interim consolidated financial statements prepared in accordance with IFRS. Unless otherwise indicated, amounts are presented in million USD.

To facilitate the understanding of AB InBev’s underlying performance, the analyses of growth, including all comments in this press release, unless otherwise indicated, are based on organic growth and normalized numbers. In other words, financials are analyzed eliminating the impact of changes in currencies on translation of foreign operations, and scope changes. Scope changes represent the impact of acquisitions and divestitures, the start or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. The results of OB are reported in the Asia Pacific zone, as a scope change, as from 1 April 2014.

All references per hectoliter (per hl) exclude US non-beer activities. To eliminate the effect of geographic mix, i.e. the impact of stronger volume growth coming from countries with lower revenue per hl, and lower Cost of Sales per hl, we are also presenting, where specified, organic growth per hectoliter figures on a constant geographic basis. When we make estimations on a constant geographic basis, we assume each country in which we operate accounts for the same percentage of our global volume as in the same period of the previous year.

Whenever presented in this document, all performance measures (EBITDA, EBIT, profit, tax rate, EPS) are presented on a “normalized” basis, which means they are presented before non-recurring items. Non-recurring items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management, and should not replace the measures determined in accordance with IFRS as an indicator of the Company’s performance. Values in the figures and annexes may not add up, due to rounding.

Effective 1 April 2014, AB InBev discontinued the reporting of volumes sold to Constellation Brands under the temporary supply agreement (TSA), since these volumes do not form part of the underlying performance of our business. The 3Q13 reference base volumes related to the TSA have therefore been treated as a negative scope.

Given the transformational nature of the transaction with Grupo Modelo that closed on 4 June 2013, and to facilitate the understanding of AB InBev’s underlying performance, AB InBev has updated its 2013 segment reporting for purposes of result announcement and internal review by senior management. This presentation (referred to as the “2013 Reference Base”) includes, for comparative purposes, the results of the Grupo Modelo business as if the combination had taken place on 4 June 2012. Accordingly, the 2013 Reference base presented in this release includes 9 months of the Grupo Modelo combination. The 2013 Reference Base further reflects updates to the 2013 segment reporting for purposes of result announcement and internal review by senior management to reflect changes in the Zone presentation of AB InBev that were effective 1 January 2014. The changes, effective 1 January 2014 include the combination of AB InBev’s Western Europe and Central & Eastern Europe Zones into a single Europe Zone, the transfer of responsibility from Global Export and Holding Companies to the Europe Zone of the company’s Spanish operations and the export of Corona to a number of European countries.

3Q14 and 9M14 EPS is based upon a weighted average of 1 633 million shares compared to 1 613 million shares for 3Q13 and 9M13.

This release contains certain forward-looking statements reflecting the current views of the management of Anheuser-Busch InBev with respect to, among other things, Anheuser-Busch InBev’s strategic objectives. These statements involve risks and uncertainties. The ability of Anheuser-Busch InBev to achieve these objectives is dependent on many factors some of which may be outside of management’s control. By their nature, forward-looking statements involve risk and uncertainty because they reflect Anheuser-Busch InBev’s current expectations and assumptions as to future events and circumstances that may not prove accurate. The actual results could differ materially from those anticipated in the forward-looking statements for many reasons including the risks described under Item 3.D of Anheuser-Busch InBev’s Annual Report on Form 20-F filed with the US Securities and Exchange Commission on 25 March 2014. Anheuser-Busch InBev cannot assure you that the future results, level of activity, performance or achievements of Anheuser-Busch InBev will meet the expectations reflected in the forward-looking statements. Anheuser-Busch InBev disclaims any obligation to update any of these statements after the date of this release.

The Third Quarter 2014 (3Q14) financial data set out in Figure 1 (except for the volume information), Figures 7 to 9, 11, 13 to 16 of this press release have been extracted from the group’s unaudited condensed consolidated interim financial statements as of and for the nine months ended 30 September 2014, which have been reviewed by our statutory auditors PricewaterhouseCoopers Bedrijfsrevisoren BCVBA in accordance with the standards of the Public Company Accounting Oversight Board (United States). The auditors concluded that, based on their review, nothing had come to their attention that caused them to believe that those interim financial statements were not presented fairly, in all material respects, in accordance with IAS 34 “Interim Financial Reporting”, as issued by the IASB and as adopted by the European Union. Financial data included in Figures 3 to 6, 10 and 12 have been extracted from the underlying accounting records as of and for the nine months ended 30 September 2014 (except for the volume information)


PRESS RELEASE

 

Brussels, 31 October 2014 – 14 / 18

   LOGO

 

CONFERENCE CALL AND WEBCAST

Investor Conference call and Webcast on Friday, 31 October 2014:

2.00pm Brussels / 1.00pm London / 9.00am New York

Registration details

Webcast (listen-only mode)

http://event.on24.com/r.htm?e=737291&s=1&k=5E21BBD821AEBE58CD44792B63E1D82B

Conference call (with interactive Q&A)

http://www.directeventreg.com/registration/event/31330956

ANHEUSER-BUSCH INBEV CONTACTS

 

Media    Investors

Marianne Amssoms

Tel: +1-212-573-9281

E-mail: marianne.amssoms@ab-inbev.com

  

Graham Staley

Tel: +1-212-573-4365

E-mail: graham.staley@ab-inbev.com

Karen Couck

Tel: +32-16-27-69-65

E-mail: karen.couck@ab-inbev.com

  

Thelke Gerdes

Tel: +32-16-27-68-88

E-mail: thelke.gerdes@ab-inbev.com

  

Christina Caspersen

Tel: +1-212-573-4376

E-mail: christina.caspersen@ab-inbev.com

About Anheuser-Busch InBev

Anheuser-Busch InBev is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). It is the leading global brewer and one of the world’s top five consumer products companies. Beer, the original social network, has been bringing people together for thousands of years and our portfolio of well over 200 beer brands continues to forge strong connections with consumers. This includes global brands Budweiser®, Corona® and Stella Artois®; international brands Beck’s®, Leffe®, and Hoegaarden®; and local champions Bud Light®, Skol®, Brahma®, Antarctica®, Quilmes®, Victoria®, Modelo Especial®, Michelob Ultra®, Harbin®, Sedrin®, Klinskoye®, Sibirskaya Korona®, Chernigivske®, Cass®, and Jupiler®. Anheuser-Busch InBev’s dedication to heritage and quality originates from the Den Hoorn brewery in Leuven, Belgium dating back to 1366 and the pioneering spirit of the Anheuser & Co brewery, with origins in St. Louis, USA since 1852. Geographically diversified with a balanced exposure to developed and developing markets, Anheuser-Busch InBev leverages the collective strengths of its approximately 155 000 employees based in 25 countries worldwide. In 2013, AB InBev realized 43.2 billion USD revenue. The company strives to be the Best Beer Company Bringing People Together For a Better World. Learn more at ab-inbev.com, at facebook.com/ABInBev or on Twitter through @ABInBevNews.


PRESS RELEASE

 

Brussels, 31 October 2014 – 15 / 18

   LOGO

 

Annex 1         

Scope

                            
AB InBev Worldwide    3Q13        Currency      Organic      3Q14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     119 664        4 000         —           -3 013         120 651        -2.6

of which AB InBev own beer

     107 907        3 526         —           -2 906         108 527        -2.7

Revenue

     11 712        434         -173         267         12 239        2.3

Cost of sales

     -4 750        -156         75         -136         -4 966        -2.9

Gross profit

     6 962        278         -98         132         7 273        1.9

Distribution expenses

     -1 076        -46         21         -98         -1 199        -9.0

Sales and marketing expenses

     -1 610        -100         15         -115         -1 809        -7.2

Administrative expenses

     -662        -15         4         23         -651        3.5

Other operating income/(expenses)

     289        -41         2         30         281        11.8

Normalized EBIT

     3 904        74         -54         -28         3 895        -0.7

Normalized EBITDA

     4 659        92         -69         63         4 745        1.3

Normalized EBITDA margin

     39.8              38.8     -37 bp   
North America    3Q13     Scope      Currency      Organic      3Q14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     33 243        211         —           -1 171         32 283        -3.5

Revenue

     4 343        59         -19         -99         4 285        -2.2

Cost of sales

     -1 742        -11         4         39         -1 709        2.3

Gross profit

     2 601        48         -15         -59         2 576        -2.2

Distribution expenses

     -323        -19         3         -15         -354        -4.2

Sales and marketing expenses

     -513        -8         1         -42         -561        -7.9

Administrative expenses

     -121        -2         —           8         -115        7.0

Other operating income/(expenses)

     20        -10         -1         8         18        94.6

Normalized EBIT

     1 664        8         -11         -97         1 562        -5.8

Normalized EBITDA

     1 858        5         -12         -98         1 753        -5.3

Normalized EBITDA margin

     42.8              40.9     -132 bp   
Mexico    3Q13     Scope      Currency      Organic      3Q14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     9 311        —           —           267         9 578        2.9

Revenue

     1 150        -93         -12         87         1 132        8.2

Cost of sales

     -354        56         3         -55         -349        -18.7

Gross profit

     796        -37         -9         31         782        4.1

Distribution expenses

     -105        13         1         -15         -105        -15.6

Sales and marketing expenses

     -192        15         1         7         -169        3.8

Administrative expenses

     -112        5         1         10         -97        9.3

Other operating income/(expenses)

     53        -30         -1         32         54        —     

Normalized EBIT

     440        -34         -6         65         466        16.1

Normalized EBITDA

     533        -39         -7         81         568        16.5

Normalized EBITDA margin

     46.3              50.2     357 bp   
Latin America - North    3Q13     Scope      Currency      Organic      3Q14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     28 830        11         —           -33         28 808        -0.1

Revenue

     2 464        2         87         46         2 601        1.9

Cost of sales

     -810        —           -31         -48         -889        -6.0

Gross profit

     1 655        1         57         -1         1 711        -0.1

Distribution expenses

     -314        —           -10         -31         -356        -10.0

Sales and marketing expenses

     -257        —           -15         -37         -309        -14.6

Administrative expenses

     -114        —           -3         -18         -135        -15.8

Other operating income/(expenses)

     174        —           1         3         177        1.7

Normalized EBIT

     1 144        —           31         -85         1 089        -7.5

Normalized EBITDA

     1 306        —           34         -45         1 294        -3.5

Normalized EBITDA margin

     53.0              49.8     -278 bp   

 


PRESS RELEASE

 

Brussels, 31 October 2014 – 16 / 18

   LOGO

 

Annex 1                              

3Q14

       
Latin America - South    3Q13     Scope      Currency      Organic        Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     8 167        —           —           188         8 355        2.3

Revenue

     706        —           -196         159         668        22.6

Cost of sales

     -278        —           73         -44         -249        -15.7

Gross profit

     428        —           -123         115         419        27.1

Distribution expenses

     -73        —           26         -22         -69        -30.0

Sales and marketing expenses

     -75        —           18         -10         -67        -13.2

Administrative expenses

     -27        —           5         —           -23        0.9

Other operating income/(expenses)

     —          —           3         -8         -6        —     

Normalized EBIT

     252        —           -72         76         254        30.1

Normalized EBITDA

     301        —           -83         80         297        26.6

Normalized EBITDA margin

     42.6              44.5     139 bp   
Europe    3Q13     Scope      Currency      Organic      3Q14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     13 119        37         —           -1 243         11 912        -9.5

of which AB InBev own beer

     12 604        36         —           -1 193         11 447        -9.5

Revenue

     1 391        3         -21         -59         1 313        -4.2

Cost of sales

     -608        -2         18         47         -546        7.7

Gross profit

     783        —           -3         -11         768        -1.5

Distribution expenses

     -133        —           2         6         -126        4.4

Sales and marketing expenses

     -284        -3         7         -8         -287        -2.8

Administrative expenses

     -81        1         2         5         -72        5.9

Other operating income/(expenses)

     10        —           —           -3         7        -31.1

Normalized EBIT

     295        -1         8         -13         289        -4.2

Normalized EBITDA

     416        —           3         -19         400        -4.5

Normalized EBITDA margin

     29.9              30.5     -9 bp   
Asia Pacific    3Q13     Scope      Currency      Organic      3Q14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     23 022        5 592         —           -1 087         27 527        -4.7

Revenue

     1 100        482         -10         55         1 626        4.9

Cost of sales

     -565        -217         5         -27         -804        -4.8

Gross profit

     535        265         -5         27         822        5.0

Distribution expenses

     -92        -40         —           -9         -141        -10.3

Sales and marketing expenses

     -243        -104         3         -20         -365        -8.2

Administrative expenses

     -90        -17         —           3         -103        3.1

Other operating income/(expenses)

     20        -1         —           5         25        26.8

Normalized EBIT

     130        103         -2         6         237        4.3

Normalized EBITDA

     227        127         -2         44         395        19.3

Normalized EBITDA margin

     20.6              24.3     283 bp   
Global Export and Holding Companies    3Q13     Scope      Currency      Organic      3Q14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     3 972        -1 849         —           65         2 187        3.0

Revenue

     558        -19         -3         79         614        14.4

Cost of sales

     -393        18         2         -47         -420        -12.6

Gross profit

     165        -1         —           30         194        18.5

Distribution expenses

     -36        —           —           -12         -48        -32.4

Sales and marketing expenses

     -46        1         —           -5         -50        -11.4

Administrative expenses

     -116        -2         -2         15         -106        12.3

Other operating income/(expenses)

     13        —           1         -7         6        -57.4

Normalized EBIT

     -20        -1         -2         21         -2        —     

Normalized EBITDA

     20        -1         -1         20         38        94.0


PRESS RELEASE

 

Brussels, 31 October 2014 – 17 / 18

   LOGO

 

Annex 2                                        
AB InBev Worldwide    9M13     Scope      Currency      Organic      9M14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     335 344        7 764         —           2 539         345 646        0.8

of which AB InBev own beer

     300 884        6 803         —           1 672         309 359        0.6

Revenue

     33 787        937         -1 459         1 781         35 045        5.3

Cost of sales

     -14 080        -348         555         -248         -14 120        -1.8

Gross profit

     19 707        589         -904         1 534         20 925        7.8

Distribution expenses

     -3 241        -107         184         -260         -3 424        -7.9

Sales and marketing expenses

     -4 862        -200         185         -539         -5 415        -11.1

Administrative expenses

     -1 965        -41         50         -53         -2 010        -2.7

Other operating income/(expenses)

     800        184         -34         49         1 000        6.5

Normalized EBIT

     10 439        424         -518         731         11 076        7.0

Normalized EBITDA

     12 748        465         -617         879         13 476        6.9

Normalized EBITDA margin

     37.7              38.5     59 bp   
North America    9M13     Scope      Currency      Organic      9M14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     93 968        496         —           -1 660         92 805        -1.8

Revenue

     12 305        123         -88         -43         12 297        -0.3

Cost of sales

     -5 008        -26         20         146         -4 867        2.9

Gross profit

     7 297        97         -68         103         7 430        1.4

Distribution expenses

     -958        -42         16         -19         -1 003        -1.9

Sales and marketing expenses

     -1 438        -18         12         -191         -1 635        -13.1

Administrative expenses

     -352        -11         3         4         -356        1.2

Other operating income/(expenses)

     51        215         -1         10         276        24.3

Normalized EBIT

     4 599        240         -37         -91         4 711        -2.0

Normalized EBITDA

     5 178        232         -40         -103         5 267        -2.0

Normalized EBITDA margin

     42.1              42.8     -69 bp   
Mexico    9M13     Scope      Currency      Organic      9M14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     28 451        —           —           503         28 954        1.8

Revenue

     3 486        -93         -93         171         3 471        5.0

Cost of sales

     -1 208        56         28         65         -1 058        5.6

Gross profit

     2 278        -37         -65         236         2 412        10.5

Distribution expenses

     -354        13         9         -13         -344        -3.7

Sales and marketing expenses

     -624        15         16         -1         -595        -0.2

Administrative expenses

     -370        5         9         17         -339        4.8

Other operating income/(expenses)

     157        -30         -5         57         179        45.0

Normalized EBIT

     1 087        -34         -35         296         1 314        28.1

Normalized EBITDA

     1 369        -39         -44         343         1 630        25.8

Normalized EBITDA margin

     39.3              47.0     775 bp   
Latin America - North    9M13     Scope      Currency      Organic      9M14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     84 654        21         —           4 498         89 173        5.3

Revenue

     7 582        3         -599         827         7 814        10.9

Cost of sales

     -2 571        -1         203         -339         -2 708        -13.2

Gross profit

     5 011        2         -395         489         5 105        9.7

Distribution expenses

     -986        —           80         -128         -1 035        -13.0

Sales and marketing expenses

     -954        —           76         -133         -1 011        -14.0

Administrative expenses

     -380        —           30         -35         -385        -9.3

Other operating income/(expenses)

     476        —           -35         -6         435        -1.2

Normalized EBIT

     3 167        1         -244         186         3 110        5.9

Normalized EBITDA

     3 708        1         -287         249         3 671        6.7

Normalized EBITDA margin

     48.9              47.0     -185 bp   

 


PRESS RELEASE

 

Brussels, 31 October 2014 – 18 / 18

   LOGO

 

Annex 2         

Scope

                  

9M14

       
Latin America - South    9M13        Currency      Organic        Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     25 540        —           —           239         25 779        0.9

Revenue

     2 226        —           -636         389         1 979        17.5

Cost of sales

     -872        —           251         -120         -741        -13.7

Gross profit

     1 354        —           -385         269         1 238        19.9

Distribution expenses

     -225        —           78         -56         -202        -24.8

Sales and marketing expenses

     -255        —           72         -57         -240        -22.3

Administrative expenses

     -79        —           15         -7         -72        -8.8

Other operating income/(expenses)

     -10        —           5         -7         -12        -74.2

Normalized EBIT

     786        —           -216         143         712        18.2

Normalized EBITDA

     929        —           -253         163         839        17.6

Normalized EBITDA margin

     41.7              42.4     3 bp   
Europe    9M13     Scope      Currency      Organic      9M14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     36 479        41         —           -2 374         34 146        -6.5

of which AB InBev own beer

     35 145        41         —           -2 341         32 845        -6.7

Revenue

     3 807        4         -24         9         3 796        0.2

Cost of sales

     -1 721        -3         36         73         -1 615        4.3

Gross profit

     2 086        1         12         83         2 181        4.0

Distribution expenses

     -385        —           3         8         -375        2.0

Sales and marketing expenses

     -813        -5         13         -60         -865        -7.3

Administrative expenses

     -247        4         2         -13         -254        -5.4

Other operating income/(expenses)

     20        —           —           -5         15        -25.4

Normalized EBIT

     660        —           30         12         702        1.8

Normalized EBITDA

     1 021        1         20         -10         1 032        -0.9

Normalized EBITDA margin

     26.8              27.2     -32 bp   
Asia Pacific    9M13     Scope      Currency      Organic      9M14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     54 543        11 526         —           992         67 062        1.8

Revenue

     2 718        956         -5         307         3 976        11.3

Cost of sales

     -1 481        -400         3         -78         -1 956        -5.3

Gross profit

     1 237        556         -2         229         2 020        18.5

Distribution expenses

     -229        -78         —           -22         -329        -9.7

Sales and marketing expenses

     -633        -193         1         -67         -892        -10.5

Administrative expenses

     -236        -34         —           -6         -275        -2.7

Other operating income/(expenses)

     68        -1         —           16         84        24.0

Normalized EBIT

     208        250         -1         150         607        72.1

Normalized EBITDA

     496        303         -1         201         999        40.4

Normalized EBITDA margin

     18.3              25.1     478 bp   
Global Export and Holding Companies    9M13     Scope      Currency      Organic      9M14     Organic  
   Reference Base        translation      growth        growth  

Total volumes (thousand hls)

     11 708        -4 321         —           340         7 726        4.6

Revenue

     1 663        -56         -15         121         1 712        7.5

Cost of sales

     -1 218        26         13         5         -1 174        0.4

Gross profit

     444        -30         -1         125         538        30.1

Distribution expenses

     -105        —           -2         -30         -136        -28.7

Sales and marketing expenses

     -144        2         -5         -31         -178        -21.6

Administrative expenses

     -301        -5         -9         -13         -328        -4.3

Other operating income/(expenses)

     37        —           2         -16         23        -41.1

Normalized EBIT

     -68        -33         -15         35         -80        36.3

Normalized EBITDA

     47        -33         -12         36         38        —     

Normalized EBITDA margin

               

 

Top
Filing Submission 0001193125-14-392221   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 3:18:14.1am ET